Healthcare Industry News

This week in Episode 3, Lisa Ling interviews National Academies member and University of Connecticut professor Cato Laurencin, M.D., Ph.D., to learn what his new coronavirus study reveals. Plus, what’s needed to mass-produce a vaccine.

This week, Lisa Ling speaks with three leading scientists who have been on the frontlines of Zika, malaria and HIV to give you the inside scoop on the latest in the development of a coronavirus vaccine, and the process of going from lab to clinic.

The Stand for Small coalition will provide millions of U.S. small businesses access to support through valuable services, offers, tools and expertise, among other benefits.

Verizon is donating $3 million to the COVID-19 Solidarity Response Fund for the World Health Organization (WHO) as part of a partnership with Global Citizens One World: Together At Home.

Johnson & Johnson scientists are fast at work on a potential vaccine for Covid-19 that our company plans to provide on a not-for-profit basis.

UPS (NYSE: UPS) today detailed a comprehensive set of actions it has taken to fight COVID-19 and to keep the American and global economy moving.

Weeks before many people had even heard of the novel coronavirus, Roland Zahn, Ph.D., was already studying the disease—specifically, how it could be stopped.​

Ware2Go, a UPS (NYSE:UPS) company that helps merchants simplify fast delivery to customers, is partnering with 1M Masks, a New York City grassroots initiative, to ship one million medical masks to healthcare workers, quickly and at no cost.

In Episode 1 of The Road to A Vaccine series, Lisa Ling interviews scientists and healthcare workers about how vaccines work, the impact of the novel coronavirus and what’s being done globally to create a COVID-19 vaccine.